These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37835569)

  • 1. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
    Gok Yavuz B; Datar S; Chamseddine S; Mohamed YI; LaPelusa M; Lee SS; Hu ZI; Koay EJ; Tran Cao HS; Jalal PK; Daniel-MacDougall C; Hassan M; Duda DG; Amin HM; Kaseb AO
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
    Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma.
    Shen S; Khatiwada S; Behary J; Kim R; Zekry A
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
    Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
    Schwabe RF; Greten TF
    J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of gut microbiota in hepatocellular carcinoma.
    Li K; Liu J; Qin X
    J Clin Lab Anal; 2022 Jul; 36(7):e24512. PubMed ID: 35719048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
    Kang Y; Cai Y; Yang Y
    Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome.
    Vaziri F; Colquhoun S; Wan YY
    Liver Res; 2020 Dec; 4(4):191-198. PubMed ID: 33343967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma.
    Zheng C; Lu F; Chen B; Yang J; Yu H; Wang D; Xie H; Chen K; Xie Y; Li J; Bo Z; Wang Y; Chen G; Deng T
    Cancer Sci; 2023 Dec; 114(12):4717-4731. PubMed ID: 37778742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
    Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
    Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target.
    Zhang M; Liu J; Xia Q
    Exp Hematol Oncol; 2023 Sep; 12(1):84. PubMed ID: 37770953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
    Li Z; Zhang Y; Hong W; Wang B; Chen Y; Yang P; Zhou J; Fan J; Zeng Z; Du S
    Gut Microbes; 2022; 14(1):2119055. PubMed ID: 36093568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti-PD-1 based immunotherapy in hepatocellular carcinoma.
    Wu H; Zheng X; Pan T; Yang X; Chen X; Zhang B; Peng L; Xie C
    Int J Cancer; 2022 Oct; 151(8):1321-1334. PubMed ID: 35579980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment.
    Yu J; Chen X; Yang X; Zhang B
    Trends Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38969601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
    Das BK
    APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma.
    Yoshikawa S; Taniguchi K; Sawamura H; Ikeda Y; Asai T; Tsuji A; Matsuda S
    Explor Target Antitumor Ther; 2023; 4(4):556-568. PubMed ID: 37720344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.